Cargando…
CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
BACKGROUND: It is highly desirable to develop new therapeutic strategies for gastric cancer given the low survival rate despite improvement in the past decades. Cadherin 17 (CDH17) is a membrane protein highly expressed in cancers of digestive system. Nanobody represents a novel antibody format for...
Autores principales: | Ma, Jingbo, Xu, Xiaolong, Fu, Chunjin, Xia, Peng, Tian, Ming, Zheng, Liuhai, Chen, Kun, Liu, Xiaolian, Li, Yilei, Yu, Le, Zhu, Qinchang, Yu, Yangyang, Fan, Rongrong, Jiang, Haibo, Li, Zhifen, Yang, Chuanbin, Xu, Chengchao, Long, Ying, Wang, Jigang, Li, Zhijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701387/ https://www.ncbi.nlm.nih.gov/pubmed/36435809 http://dx.doi.org/10.1186/s40824-022-00312-3 |
Ejemplares similares
-
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
por: Narbona, Javier, et al.
Publicado: (2023) -
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
por: Yu, Yuan, et al.
Publicado: (2017) -
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
por: Wang, Huifang, et al.
Publicado: (2023) -
Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells
por: Tang, Jinle, et al.
Publicado: (2016) -
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
por: Deng, Cuimin, et al.
Publicado: (2017)